Product Information
CYCLOSPORINE 25 MG CAPSULE is a generic product labeled by American Health Packaging, priced at $2.5957 per EA under NDC 68084087925. Its NADAC has been published 566 times since Dec 2, 2015.
FDA first approved this application on May 9, 2002. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
American Health PackagingNDC
68084087925
Classification
Generic
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CYCLOSPORINEApproval Type
Generic (ANDA)
FDA Application
ANDA065040FDA Approved
5/9/2002
TE Code
AB2
On Market Since
9/30/2015
Pharmacological Classes
Price Statistics
The NADAC for CYCLOSPORINE 25 MG CAPSULE has been published 566 times since Dec 2, 2015, and over the history we have for it it has risen 41.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5957 per EA |
|---|---|
| All-time high | $2.8796 (Feb 11, 2026) |
| All-time low | $1.7967 (Mar 23, 2016) |
| 52-week high | $2.8796 |
| 52-week low | $2.5776 |
| Median price | $2.3009 |
| Average price | $2.2986 |
| Largest weekly change | -20.0% (Oct 21, 2020) |
| Weeks tracked | 566 |
| Tracking since | Dec 2, 2015 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 88% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
American Health Packaging manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cyclosporine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcineurin Inhibitor Immunosuppressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CYCLOSPORINE 25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOSPORINE 25 MG CAPSULE, manufactured by American Health Packaging, is $2.5957 per EA (NDC 68084087925), effective Sep 30, 2026.
How has the price of CYCLOSPORINE 25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CYCLOSPORINE 25 MG CAPSULE has risen 41.4%. It has been tracked across 566 weekly CMS publications since Dec 2, 2015.
What are the highest and lowest recorded NADAC prices for CYCLOSPORINE 25 MG CAPSULE?
Since Dec 2, 2015, the NADAC for CYCLOSPORINE 25 MG CAPSULE has ranged from a low of $1.7967 (Mar 23, 2016) to a high of $2.8796 (Feb 11, 2026), with a median of $2.3009 per EA.
Are there cheaper alternatives to CYCLOSPORINE 25 MG CAPSULE?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CYCLOSPORINE MODIFIED 25 MG, is $0.3138 per EA — about 88% below CYCLOSPORINE 25 MG CAPSULE.
Who manufactures CYCLOSPORINE 25 MG CAPSULE?
CYCLOSPORINE 25 MG CAPSULE (NDC 68084087925) is labeled by American Health Packaging, and CMS classifies it as a generic product.